Caren van Roekel

160 Chapter 5 50. Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, et al. Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. Clin Colorect Cancer. 2018;17(4):e617-e29. 51. Duffy MJ. Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful? Clinical Chemistry. 2001;47(4):624-30. 52. Ziv E, Bergen M, Yarmohammadi H, Boas FE, Petre EN, Sofocleous CT, et al. PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases. Oncotarget. 2017;8(14):23529-38. 53. Frankema-Mourer JS, Heymans J. Standpunt Yttrium-90 radioembolisatie bij colorectale levermetastasen. Zorginstituut Nederland. 2016. 54. Virdee PS, Moschandreas J, Gebski V, Love SB, Francis EA, Wasan HS, et al. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE- Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR Research Protocols. 2017;6(3):e43. 55. Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol. 2017;18(9):1159-71. 56. Ulrich G, Dudeck O, Furth C, Ruf J, Grosser OS, Adolf D, et al. Predictive value of intratumoral 99mTc- macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. J Nucl Med. 2013;54(4):516-22. 57. Jongen JMJ, Rosenbaum C, Braat M, van den Bosch M, Sze DY, Kranenburg O, et al. Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment. J Vasc Interv Radiol. 2018;29(2):244-53 e2. 58. Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol. 2010;28(23):3687-94. 59. Braat AJAT, Kappadath SC, Bruijnen RC, Van den Hoven AF, Mahvash A, De Jong HW, et al. Adequate SIRT activity dose is as important as adequate chemotherapy dose. Lancet Oncol. 2017;18:e636.